30
Participants
Start Date
May 31, 2011
Primary Completion Date
June 30, 2012
Study Completion Date
July 31, 2012
Kibow Biotics
Month 1, one capsule three times daily (90 Colony forming units); Month 2, two capsules three times daily (180 CFU's); Month 3, three capsules three times daily (270 CFU's). Continued on tolerated maintenance dosage for an additional 6 months. Once tolerated dosage is identified the patient will be continued on that maintenance dosage for an additional 6 months. All medical, physical, clinical, QOL and other parameters will be monitored as well.
Thomas Jefferson University, Philadelphia
Lead Sponsor
Thomas Jefferson University
OTHER
Kibow Pharma
INDUSTRY